Volume depletion

[5C70](/pt/code/5C70) - Volume Depletion: Complete Coding and Clinical Application Guide 1. Introduction Volume depletion, coded as 5C70 in the International Classification of Diseases -

Partager

5C70 - Volume Depletion: Complete Coding and Clinical Application Guide

1. Introduction

Volume depletion, coded as 5C70 in the International Classification of Diseases - 11th Revision (ICD-11), represents a fundamental clinical condition characterized by reduction in extracellular fluid volume, particularly in the intravascular compartment. This disorder occurs when losses of water and electrolytes exceed intake, resulting in decreased effective circulating volume that may compromise tissue perfusion and organ function.

The clinical importance of volume depletion transcends geographic boundaries and healthcare systems, manifesting as one of the most common causes of hospital admission in emergency departments globally. This condition affects patients of all age groups, from infants with acute gastroenteritis to elderly patients with multiple comorbidities, becoming especially relevant in vulnerable populations.

From a public health perspective, volume depletion represents a significant challenge. When undiagnosed or inadequately treated, it can progress to serious complications such as acute kidney injury, hypovolemic shock, and multiple organ failure. The morbidity and mortality associated with this condition generates substantial costs for healthcare systems worldwide, especially when diagnosis is delayed.

Correct coding of volume depletion is critical for multiple reasons: it enables precise epidemiological tracking, facilitates appropriate allocation of hospital resources, ensures appropriate reimbursement in diagnosis-based systems, and contributes to clinical research and development of therapeutic protocols. Appropriate distinction between volume depletion and other related hydroelectrolytic disorders is essential for effective clinical management and for communication among healthcare professionals.

2. Correct ICD-11 Code

Code: 5C70

Description: Volume depletion

Parent category: Disorders of fluid, electrolyte or acid-base balance

Code 5C70 specifically identifies the reduction of extracellular fluid volume, distinguishing itself from other hydroelectrolytic disorders that may coexist or confound the clinical presentation. This coding was developed in ICD-11 to provide greater diagnostic specificity compared to previous versions of the classification.

Volume depletion under this code refers primarily to isotonic or near-isotonic loss of body fluids, where water and electrolytes are lost in similar proportions. This characteristic differentiates the condition from purely osmotic disorders, where there is predominant imbalance of solutes in relation to water.

Code 5C70 is inserted within the hierarchical structure of disorders of fluid, electrolyte and acid-base balance, reflecting its nature as a primary alteration of circulating volume. This classification facilitates navigation between related codes and allows computerized health systems to identify patterns and relevant clinical associations.

It is important to emphasize that code 5C70 should be used when volume depletion is the predominant feature of the clinical presentation, even if secondary electrolyte alterations exist. Adequate documentation should specify the etiology of depletion when known, although the primary code remains the same.

3. When to Use This Code

Scenario 1: Acute Gastroenteritis with Dehydration

Patient presents with profuse watery diarrhea for 48 hours, associated with vomiting, with marked reduction in oral intake. Physical examination reveals dry mucous membranes, decreased skin turgor, tachycardia, and postural hypotension. Laboratory tests demonstrate hemoconcentration with discrete and proportional elevation of urea and creatinine, without significant sodium alterations. This is a classic example of volume depletion from gastrointestinal losses.

Scenario 2: Excessive Diuretic Use

Patient undergoing treatment for arterial hypertension with loop diuretics presents with weakness, dizziness upon standing, and oliguria. Investigation reveals unsupervised increase in medication dosage. Physical examination shows signs of intravascular volume contraction, and laboratory tests indicate prerenal azotemia with low urinary sodium, consistent with iatrogenic volume depletion.

Scenario 3: Excessive Cutaneous Losses

Worker exposed to high-temperature environment develops profuse diaphoresis during prolonged work shift without adequate fluid replacement. Presents with intense fatigue, muscle cramps, oliguria, and vital signs compatible with volume depletion. History of heat exposure and uncompensated fluid loss, combined with clinical findings, justifies the use of code 5C70.

Scenario 4: Fluid Sequestration in Third Space

Patient with acute pancreatitis develops significant fluid accumulation in retroperitoneal space and ascites. Despite localized edema, presents with signs of effective circulating volume depletion, including hypotension, tachycardia, and reduced urine output. Tests show hemoconcentration and prerenal renal insufficiency, indicating volume depletion from fluid redistribution.

Scenario 5: Excessive Renal Losses

Patient with uncontrolled nephrogenic or central diabetes insipidus presents with marked polyuria with inability to maintain adequate fluid intake. Develops clinical signs of volume depletion, including dry mucous membranes, hypotension, and tachycardia. Laboratory tests may show associated hypernatremia, but the predominant feature is depletion of circulating volume.

Scenario 6: Chronic Occult Hemorrhage

Patient with chronic low-volume gastrointestinal bleeding, such as from angiodysplasia or erosive gastritis, progressively develops signs of volume depletion. Presents with iron deficiency anemia, tachycardia, postural hypotension, and signs of peripheral hypoperfusion. Although anemia is significant, circulating volume depletion is the predominant clinical manifestation requiring coding.

4. When NOT to Use This Code

The code 5C70 should not be used when the predominant clinical condition is established hypovolemic shock, characterized by severe tissue hypoperfusion with acute organ dysfunction. In these cases, the appropriate code is 284999005 (Hypovolemic shock), which represents a more severe and potentially fatal condition that requires immediate and intensive intervention. The differentiation is based on the presence of signs of circulatory failure, such as altered level of consciousness, severe metabolic acidosis, elevated lactate, and evidence of multiple organ dysfunction.

Do not use 5C70 when the primary disorder is alteration of plasma osmolality without significant volume depletion. Patients with pure hypernatremia due to free water loss (such as in well-compensated diabetes insipidus with preserved circulating volume) should be coded as 5C71 (Hyperosmolality or hypernatremia). Similarly, cases of dilutional hyponatremia without volume depletion, such as in syndrome of inappropriate antidiuretic hormone secretion, should receive code 5C72 (Hyposmolality or hyponatremia).

Avoid using this code when the clinical presentation is dominated by acid-base disorders, even if some degree of volume depletion exists. For example, patients in diabetic ketoacidosis or severe lactic acidosis should be primarily coded with 5C73 (Acidosis), with code 5C70 being added as a secondary diagnosis if volume depletion is clinically significant and requires specific treatment.

Code 5C70 is also not appropriate for edema or volume overload, opposite conditions that require different coding. Patients with congestive heart failure, nephrotic syndrome, or cirrhosis with ascites present expansion of extracellular volume, not depletion.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Confirmation of volume depletion begins with systematic clinical evaluation. Physical examination should include verification of vital signs in supine and orthostatic positions, assessment of skin turgor (preferably in the sternal region in adults), examination of mucous membranes, capillary refill time, and evaluation of mental status. The presence of tachycardia, orthostatic hypotension (systolic blood pressure drop greater than 20 mmHg or diastolic drop greater than 10 mmHg upon standing), dry mucous membranes, and decreased skin turgor are important indicators.

Essential laboratory instruments include complete blood count (to assess hemoconcentration through elevated hematocrit), serum electrolytes, urea and creatinine (to identify prerenal azotemia), and urinalysis with urinary sodium. An elevated urea/creatinine ratio (typically above 20:1) suggests volume depletion. Low urinary sodium (generally below 20 mEq/L) indicates compensatory renal sodium retention, except when the cause of depletion is renal.

Complementary evaluations may include arterial blood gas analysis to assess tissue perfusion through lactate and base excess, and ultrasonography to assess the inferior vena cava in equivocal cases. Integration of these clinical and laboratory data confirms the diagnosis of volume depletion.

Step 2: Verify Specifiers

Determine the severity of volume depletion based on clinical and laboratory criteria. Mild depletion generally presents with minimal symptoms and preserved vital signs. Moderate depletion manifests with tachycardia, orthostatic hypotension, and oliguria. Severe depletion approaches hypovolemic shock, with hypotension even at rest and signs of organ hypoperfusion.

Identify the duration of the condition: acute (hours to days) versus chronic (weeks to months). This distinction influences the therapeutic approach, especially the rate of volume replacement. Characterize the predominant pathophysiological mechanism: gastrointestinal losses, renal losses, cutaneous losses, sequestration in third space, or hemorrhage.

Document the presence of associated complications, such as prerenal acute kidney injury, secondary electrolyte disturbances, or hemodynamic compromise. This information, although it does not alter the primary code 5C70, is essential for complete coding and therapeutic planning.

Step 3: Differentiate from Other Codes

5C71 - Hyperosmolality or hypernatremia: The key difference lies in the predominance of osmotic alteration. While 5C70 refers to isotonic loss of fluids (water and electrolytes in similar proportions), 5C71 involves disproportionate loss of free water or sodium gain, resulting in elevated plasma osmolality (typically above 295 mOsm/kg) and serum sodium above 145 mEq/L. Use 5C71 when hypernatremia is the dominant feature, even if some volume depletion exists.

5C72 - Hyposmolality or hyponatremia: This condition is characterized by relative excess of water in relation to sodium, with reduced plasma osmolality (below 275 mOsm/kg) and serum sodium below 135 mEq/L. Unlike 5C70, where there is depletion of circulating volume, 5C72 may occur with normal or even expanded volume. The critical distinction is that in pure volume depletion, sodium remains in the normal range or is only slightly altered.

5C73 - Acidosis: This code applies when the primary disorder is reduction of blood pH (below 7.35) with accumulation of acids or loss of bases. Although volume depletion may cause secondary metabolic acidosis (through hypoperfusion and lactate accumulation), use 5C73 when acidosis is the predominant manifestation, as in diabetic ketoacidosis or primary lactic acidosis.

Step 4: Required Documentation

Checklist of Mandatory Information:

  • Detailed description of signs and symptoms present
  • Vital signs including orthostatic measurements when applicable
  • Physical examination findings related to hydration status
  • Pertinent laboratory results with numerical values
  • Probable or confirmed etiology of volume depletion
  • Estimated severity of the condition
  • Initial response to treatment when available
  • Associated complications if present

Appropriate documentation should include the justification for the diagnosis of volume depletion, differentiating it from other diagnostic possibilities considered. Specifically document why other related codes were excluded. This documentation not only supports appropriate coding but also facilitates continuity of care and provides legal protection for the healthcare professional.

Record the temporal evolution of the condition, including when symptoms began, identified precipitating factors, and any previous treatment attempts. This chronological narrative strengthens clinical documentation and justifies therapeutic decisions.

6. Complete Practical Example

Clinical Case

A 67-year-old patient presents to the emergency department with complaints of progressive weakness, dizziness upon standing, and reduced urine output for three days. He reports that five days ago he developed liquid diarrhea, with approximately eight bowel movements daily, without visible blood or mucus. Additionally, he experienced intermittent nausea and vomiting, with significant reduction in food and fluid intake. He denies fever but reports intense thirst.

In his past medical history, hypertension stands out, for which he regularly uses enalapril 20 mg daily and hydrochlorothiazide 25 mg daily. He denies other comorbidities or use of other medications. He lives alone and has difficulty accessing fresh food.

On physical examination, the patient appears conscious and oriented but visibly uncomfortable. Vital signs in supine position: blood pressure 100/60 mmHg, heart rate 98 bpm, respiratory rate 18 breaths/min, axillary temperature 36.8°C. In orthostatic position: blood pressure 80/50 mmHg, heart rate 118 bpm. Oral and conjunctival mucous membranes are dry, with decreased skin turgor in the sternal region. Cardiopulmonary auscultation without abnormalities. Abdomen flat, hyperactive bowel sounds, without masses or visceromegaly. Extremities with preserved peripheral perfusion, without edema.

Initial laboratory tests revealed: hemoglobin 16.5 g/dL (previous from six months ago: 14.2 g/dL), hematocrit 49% (previous: 42%), leukocytes 11,200/mm³, platelets 285,000/mm³. Serum sodium 138 mEq/L, potassium 3.8 mEq/L, chloride 102 mEq/L, bicarbonate 22 mEq/L. Blood urea nitrogen 68 mg/dL, creatinine 1.8 mg/dL (previous: 1.0 mg/dL), blood urea nitrogen/creatinine ratio 37.7:1. Blood glucose 102 mg/dL. Urinalysis: specific gravity 1.030, pH 5.5, without abnormal elements. Urinary sodium 12 mEq/L.

Step-by-Step Coding

Criteria Analysis:

The patient presents multiple diagnostic criteria for volume depletion. Clinically, there is a clear history of significant gastrointestinal losses (diarrhea and vomiting) without adequate replacement. Vital signs demonstrate marked orthostatic hypotension (drop of 20 mmHg in systolic pressure and increase of 20 bpm in heart rate), a sensitive indicator of volume depletion. Physical examination reveals dry mucous membranes and decreased skin turgor, classic signs of dehydration.

Laboratory findings show evident hemoconcentration with hematocrit elevation from 42% to 49%, reflecting reduction in plasma volume. The blood urea nitrogen/creatinine ratio of 37.7:1 (well above the normal range of 10-20:1) is characteristic of prerenal azotemia, where increased tubular reabsorption of urea in the presence of reduced urine flow disproportionately elevates urea relative to creatinine. Low urinary sodium (12 mEq/L) confirms appropriate renal response to volume depletion, with maximal sodium retention. Elevated urine specific gravity (1.030) indicates maximal urine concentration, another renal compensatory mechanism.

It is important to note that serum sodium remains normal (138 mEq/L), indicating isotonic fluid loss, characteristic of pure volume depletion, distinguishing it from osmotic disorders. Slightly reduced bicarbonate (22 mEq/L) may reflect mild metabolic acidosis secondary to hypoperfusion, but is not the predominant disorder.

Code Selected: 5C70 - Volume depletion

Complete Justification:

Code 5C70 is appropriate because the predominant clinical manifestation is reduction in extracellular fluid volume, specifically of the intravascular compartment. The etiology is clearly identified as excessive gastrointestinal losses without adequate replacement, exacerbated by continued use of thiazide diuretic during the acute episode.

Severity can be classified as moderate to severe, based on the presence of significant orthostatic hypotension, oliguria, and prerenal acute kidney injury. However, the patient does not present signs of established hypovolemic shock (maintains systolic blood pressure above 80 mmHg at rest, is conscious and oriented, without evidence of severe organ dysfunction), which would exclude the use of 5C70 in favor of the code for hypovolemic shock.

The absence of significant sodium alterations (which remains at 138 mEq/L) excludes codes 5C71 (hyperosmolality/hypernatremia) and 5C72 (hyposmolality/hyponatremia). Metabolic acidosis is mild and secondary, not justifying primary use of code 5C73 (acidosis).

Complementary Codes:

  • Code for acute gastroenteritis (etiology of depletion)
  • Code for prerenal acute kidney injury (complication)
  • Z code for medication use (diuretic as contributing factor)

The therapeutic plan included temporary discontinuation of antihypertensive medications, initial intravenous volume replacement with isotonic saline solution, followed by transition to oral hydration as tolerated, and investigation of the cause of gastroenteritis. Clinical and laboratory response to volume replacement would confirm the diagnosis of volume depletion.

7. Related Codes and Differentiation

Within the Same Category

5C71: Hyperosmolality or hypernatremia

Use 5C71 when the predominant disorder is increased plasma osmolality (above 295 mOsm/kg) or elevated serum sodium (above 145 mEq/L), resulting from disproportionate loss of free water relative to solutes or sodium gain. The main difference from 5C70 lies in the composition of the loss: in hypernatremia, there is free water deficit, whereas in pure volume depletion, the loss is isotonic. Clinically, patients with hypernatremia frequently present neurological symptoms (confusion, irritability, seizures) due to cerebral cellular dehydration, whereas in isotonic volume depletion, symptoms relate primarily to hypoperfusion. A patient may present with both conditions simultaneously, in which case both codes may be used, with the primary code being the one representing the dominant clinical manifestation.

5C72: Hyposmolality or hyponatremia

Code 5C72 applies when there is reduction in plasma osmolality (below 275 mOsm/kg) or low serum sodium (below 135 mEq/L), indicating relative excess of water in relation to sodium. The fundamental difference versus 5C70 is that hyponatremia can occur in normal volume states (euvolemic, such as in syndrome of inappropriate antidiuretic hormone secretion) or even expanded states (hypervolemic, such as in heart failure), whereas volume depletion always involves reduction of the extracellular compartment. When a patient presents with volume depletion with associated hyponatremia (hypovolemic hyponatremia), primary coding depends on the predominant manifestation: if signs of volume depletion are more prominent and clinically significant, use 5C70; if hyponatremia is severe and symptomatic, use 5C72 as the primary code.

5C73: Acidosis

This code identifies disorders characterized by reduced blood pH (below 7.35) due to acid accumulation or base loss. The main difference from 5C70 is that acidosis represents a primary acid-base disorder, whereas volume depletion is a volume disorder. Although severe volume depletion may cause secondary metabolic acidosis (from tissue hypoperfusion with lactate production or hyperchloremic acidosis from saline solution administration), use 5C73 when acidosis is the dominant feature of the clinical presentation, such as in diabetic ketoacidosis, lactic acidosis, or renal tubular acidosis. Patients with volume depletion who develop significant acidosis may require both codes, with the order determined by clinical predominance and therapeutic necessity.

Differential Diagnoses

Congestive heart failure can mimic volume depletion when there is low cardiac output, but is distinguished by the presence of pulmonary congestion, peripheral edema, and elevated natriuretic peptides. Primary adrenal insufficiency (Addison disease) presents with chronic volume depletion with hyponatremia and hyperkalemia, differentiated by the presence of cutaneous hyperpigmentation and low cortisol levels. Intestinal obstruction can cause fluid sequestration, but presents with abdominal distension, absence of bowel sounds, and characteristic radiological findings.

8. Differences with ICD-10

In ICD-10, volume depletion was coded primarily as E86 (Volume depletion), a relatively nonspecific code within the chapter of endocrine, nutritional and metabolic diseases. ICD-11 reorganized this condition under code 5C70, situating it more appropriately within the category of disorders of fluid, electrolyte, and acid-base balance.

The main conceptual change in ICD-11 is greater specificity and clearer separation between volume disorders and osmotic disorders. While ICD-10 frequently grouped dehydration and volume depletion under the same code, ICD-11 clearly distinguishes volume depletion (5C70) from hyperosmolality/hypernatremia (5C71), better reflecting the underlying pathophysiology.

The practical impact of these changes is significant for clinical coding. The hierarchical structure of ICD-11 facilitates navigation and selection of the appropriate code, reducing coding errors. The separation of volume, osmolality, and acid-base disorders into distinct codes allows greater diagnostic precision and better epidemiological tracking. For health systems that use coding for reimbursement, this specificity may result in payments more appropriate to case complexity.

Healthcare professionals familiar with ICD-10 should recognize that code E86 does not have a single direct correspondence in ICD-11, and may be mapped to 5C70, 5C71, or other codes depending on the specific clinical presentation, requiring more careful evaluation of clinical documentation.

9. Frequently Asked Questions

How is volume depletion diagnosed?

The diagnosis of volume depletion is essentially clinical, based on detailed history and careful physical examination. The history should investigate potential sources of fluid loss (vomiting, diarrhea, excessive sweating, diuretic use, polyuria) and reduced intake. The physical examination focuses on orthostatic vital signs, evaluation of mucous membranes, skin turgor, and peripheral perfusion. Laboratory tests complement the clinical evaluation: hemoconcentration (elevated hematocrit), prerenal azotemia (elevated urea/creatinine ratio), low urinary sodium, and elevated urine specific gravity support the diagnosis. In doubtful cases, the response to cautious volume replacement can be both diagnostic and therapeutic. More sophisticated methods, such as inferior vena cava ultrasound or bioimpedance, may be useful in specific situations, but do not replace clinical evaluation.

Is treatment available in public health systems?

Treatment of volume depletion is widely available in public health systems globally, as it consists primarily of fluid and electrolyte replacement, relatively accessible resources. Oral rehydration therapy, using standardized electrolyte solutions, is extremely cost-effective and can be administered at the ambulatory or community level for mild to moderate cases. For more severe depletion, intravenous replacement with crystalloid solutions (normal saline or lactated Ringer's) is the standard treatment, available in virtually all hospitals and emergency services. The challenge in some contexts is timely access to treatment, especially in remote areas or those with limited resources, where delays in recognition and treatment can lead to preventable complications.

How long does treatment last?

The duration of treatment varies widely depending on the severity of depletion, the underlying cause, and individual response. Mild cases of volume depletion can be corrected in 24 to 48 hours with adequate oral rehydration. Moderate to severe depletion usually requires hospitalization with intravenous replacement for two to five days, with monitoring of vital signs, urine output, and laboratory parameters. The rate of replacement must be carefully controlled, especially in patients with chronic depletion, to avoid complications such as cerebral edema or heart failure. After the acute phase, prolonged treatment of the underlying condition may be necessary (for example, medication adjustment, treatment of infections, dietary modifications) to prevent recurrence. Patients with chronic causes of volume depletion may require follow-up and therapeutic adjustments for weeks to months.

Can this code be used on medical certificates?

Yes, code 5C70 can and should be used on medical certificates when volume depletion is the condition that justifies absence from usual activities. The documentation on the certificate should include the ICD-11 code 5C70 and a comprehensible description of the condition (such as "volume depletion" or "severe dehydration") that justifies temporary incapacity. The duration of absence should be based on the severity of the condition and the nature of the patient's activities: work requiring intense physical effort or heat exposure may require longer absence than sedentary activities in a controlled environment. It is important that the certificate be specific regarding the need for rest, rehydration, and medical follow-up, providing clear justification to employers or educational institutions.

Can volume depletion cause permanent damage?

Volume depletion itself is generally reversible with adequate and timely treatment, without permanent sequelae. However, when severe or prolonged, it can lead to complications with potential for permanent damage. Prerenal acute kidney injury, if not treated rapidly, can progress to acute tubular necrosis with partial recovery of renal function. Episodes of cerebral hypoperfusion can cause neurological injury, especially in elderly patients or those with previous cerebrovascular disease. Mesenteric hypoperfusion can result in intestinal ischemia with serious complications. In young children, repeated episodes of severe volume depletion can affect neurological development. Prevention of permanent damage depends on early recognition, adequate treatment, and identification of the underlying cause to prevent recurrences.

Which populations have the highest risk of volume depletion?

Certain population groups have increased risk of developing volume depletion. Infants and young children are particularly vulnerable due to higher proportion of body water, higher metabolic rate, and dependence on caregivers for fluid intake. Elderly patients have elevated risk due to multiple factors: reduced thirst sensation, decreased renal concentrating ability, frequent use of diuretics and other medications, and higher prevalence of chronic conditions. Athletes and workers in hot environments can develop depletion from increased insensible losses. Patients with chronic diseases such as diabetes mellitus, chronic kidney disease, or heart failure have greater susceptibility. Individuals with limited access to potable water or in humanitarian crisis situations face increased risk. Recognizing these vulnerable populations allows for targeted preventive strategies.

How can episodes of volume depletion be prevented?

Prevention of volume depletion involves multiple strategies. Maintaining adequate hydration is fundamental, with fluid intake adjusted to physical activity, ambient temperature, and individual conditions. During episodes of illness with vomiting or diarrhea, early initiation of oral rehydration can prevent progression to severe depletion. Patients using diuretics should be educated about warning signs of depletion and the importance of dose adjustments during intercurrent illnesses. In high-temperature environments or during intense exercise, increase fluid and electrolyte intake preventively. Elderly patients should be encouraged to maintain regular water intake even without thirst, and caregivers should actively monitor hydration. Early recognition of signs of depletion allows for timely intervention before complications develop. Health education on symptom recognition and when to seek medical care is essential for prevention of severe cases.

Is volume depletion the same as dehydration?

Although the terms are often used interchangeably in clinical practice, technically there are distinctions. Volume depletion refers specifically to reduction in extracellular fluid volume, particularly the intravascular compartment, usually resulting from isotonic loss of water and electrolytes. Dehydration, in the strict sense, refers to loss of free water, resulting in hyperosmolality and hypernatremia, affecting both intracellular and extracellular compartments. In clinical practice, "dehydration" is commonly used to describe any fluid deficit, including what would be more precisely called volume depletion. ICD-11, with its separation between volume depletion (5C70) and hyperosmolality/hypernatremia (5C71), better reflects this pathophysiological distinction. For accurate coding, it is important to assess whether the patient has isotonic loss (volume depletion) or disproportionate water loss (hypertonic dehydration), although many patients present with mixed features.


Conclusion

Proper coding of volume depletion using ICD-11 code 5C70 requires clear understanding of pathophysiology, recognition of characteristic clinical manifestations, and careful differentiation of related conditions. This guide provides a systematic approach to identifying appropriate cases, documenting adequately, and applying the correct code, contributing to better quality of health data, optimized treatment, and efficient resource management. The transition from ICD-10 to ICD-11 offers an opportunity for greater diagnostic precision, benefiting patients, healthcare professionals, and health systems globally.

External References

This article was prepared based on reliable scientific sources:

  1. 🌍 WHO ICD-11 - Volume depletion
  2. 🔬 PubMed Research on Volume depletion
  3. 🌍 WHO Health Topics
  4. 📊 Clinical Evidence: Volume depletion
  5. 📋 Ministry of Health - Brazil
  6. 📊 Cochrane Systematic Reviews

References verified on 2026-02-04

Codes Associés

Comment Citer Cet Article

Format Vancouver

Administrador CID-11. Volume depletion. IndexICD [Internet]. 2026-02-04 [citado 2026-03-29]. Disponível em:

Utilisez cette citation dans les travaux académiques et articles scientifiques.

Partager